Galecto Trading Halted, Volatility Trading Pause
Galecto Trading Resumes
Trending Stocks Today | Impact BioMedical Shoots up 77.45%
12 Health Care Stocks Moving In Friday's Intraday Session
Galecto (GLTO) Shares Rally Amid Positive Market Momentum
Galecto, Inc. Completes Strategic Review, Acquires Global Rights to GB3226 for Oncology and Liver Disease Focus
Galecto FY24 Loss $21.4M >GLTO
Express News | Galecto FY 2024 GAAP EPS $(18.53) Misses $(15.91) Estimate
Galecto: GB3226 on Track for IND Submission in 1Q of 2026 >GLTO
Press Release: Galecto Reports Full-Year 2024 Financial Results
Galecto | 10-K: FY2024 Annual Report
Galecto to Participate in Upcoming Investor Conferences
Galecto Anticipates That Its Cash, Cash Equivalents and Investments Will Be Sufficient to Fund Operating Expenses and Cap Requirements for at Least the Next Twelve Mos >GLTO
Galecto Cash, Cash Equivalents, and Investments as of Sept 30 Were $19.7M >GLTO
Express News | Galecto Reports Third Quarter 2024 Financial Results
Galecto 3Q Loss/Shr $3.39 >GLTO
Galecto 3Q Loss $3.88M >GLTO
Press Release: Galecto Reports Third Quarter 2024 Financial Results
Galecto | 10-Q: Q3 2024 Earnings Report
Galecto Is Maintained at Outperform by Oppenheimer